Fehse B - Search Results

1

Membrane-anchored peptide inhibits human immunodeficiency virus entry.

Hildinger M, Dittmar MT, Schult-Dietrich P, Fehse B, Schnierle BS, Thaler S, Stiegler G, Welker R, von Laer D. Hildinger M, et al. Among authors: fehse b. J Virol. 2001 Mar;75(6):3038-42. doi: 10.1128/JVI.75.6.3038-3042.2001. J Virol. 2001. PMID: 11222732 Free PMC article.

2

Dominant selection of hematopoietic progenitor cells with retroviral MDR1 co-expression vectors.

Hildinger M, Fehse B, Hegewisch-Becker S, John J, Rafferty JR, Ostertag W, Baum C. Hildinger M, et al. Among authors: fehse b. Hum Gene Ther. 1998 Jan 1;9(1):33-42. doi: 10.1089/hum.1998.9.1-33. Hum Gene Ther. 1998. PMID: 9458240

3

Bicistronic retroviral vectors for combining myeloprotection with cell-surface marking.

Hildinger M, Schilz A, Eckert HG, Bohn W, Fehse B, Zander A, Ostertag W, Baum C. Hildinger M, et al. Among authors: fehse b. Gene Ther. 1999 Jul;6(7):1222-30. doi: 10.1038/sj.gt.3300942. Gene Ther. 1999. PMID: 10455430

4

Amphotropic and VSV-G-pseudotyped retroviral vectors transduce human hematopoietic progenitor cells with similar efficiency.

von Laer D, Corovic A, Vogt B, Herwig U, Roscher S, Fehse B, Baum C. von Laer D, et al. Among authors: fehse b. Bone Marrow Transplant. 2000 May;25 Suppl 2:S75-9. doi: 10.1038/sj.bmt.1702360. Bone Marrow Transplant. 2000. PMID: 10933195

5

Simplified generation of high-titer retrovirus producer cells for clinically relevant retroviral vectors by reversible inclusion of a lox-P-flanked marker gene.

Loew R, Selevsek N, Fehse B, von Laer D, Baum C, Fauser A, Kuehlcke K. Loew R, et al. Among authors: fehse b. Mol Ther. 2004 May;9(5):738-46. doi: 10.1016/j.ymthe.2004.02.010. Mol Ther. 2004. PMID: 15120335 Free article.

6

Self-inactivating retroviral vectors with improved RNA processing.

Kraunus J, Schaumann DH, Meyer J, Modlich U, Fehse B, Brandenburg G, von Laer D, Klump H, Schambach A, Bohne J, Baum C. Kraunus J, et al. Among authors: fehse b. Gene Ther. 2004 Nov;11(21):1568-78. doi: 10.1038/sj.gt.3302309. Gene Ther. 2004. PMID: 15372067

7

TK.007: A novel, codon-optimized HSVtk(A168H) mutant for suicide gene therapy.

Preuss E, Treschow A, Newrzela S, Brücher D, Weber K, Felldin U, Alici E, Gahrton G, von Laer D, Dilber MS, Fehse B. Preuss E, et al. Among authors: fehse b. Hum Gene Ther. 2010 Aug;21(8):929-41. doi: 10.1089/hum.2009.042. Hum Gene Ther. 2010. PMID: 20201626

8

Cancer suicide gene therapy with TK.007: superior killing efficiency and bystander effect.

Preuss E, Muik A, Weber K, Otte J, von Laer D, Fehse B. Preuss E, et al. Among authors: fehse b. J Mol Med (Berl). 2011 Nov;89(11):1113-24. doi: 10.1007/s00109-011-0777-8. Epub 2011 Jun 23. J Mol Med (Berl). 2011. PMID: 21698427

9

Retroviral insertional mutagenesis can contribute to immortalization of mature T lymphocytes.

Newrzela S, Cornils K, Heinrich T, Schläger J, Yi JH, Lysenko O, Kimpel J, Fehse B, von Laer D. Newrzela S, et al. Among authors: fehse b. Mol Med. 2011;17(11-12):1223-32. doi: 10.2119/molmed.2010.00193. Epub 2011 Jul 27. Mol Med. 2011. PMID: 21826372 Free PMC article.

10

Excision of specific DNA-sequences from integrated retroviral vectors via site-specific recombination.

Bergemann J, Kühlcke K, Fehse B, Ratz I, Ostertag W, Lother H. Bergemann J, et al. Among authors: fehse b. Nucleic Acids Res. 1995 Nov 11;23(21):4451-6. doi: 10.1093/nar/23.21.4451. Nucleic Acids Res. 1995. PMID: 7501469 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

262 results

Search Page

Filters